Medication-info.com Search Menu

Vaqta: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
25 IU/0.5 mL, 50 IU/mL
Similar drugs:

Patient information: uses, side effects, how to take - Vaqta

What is VAQTA?

  • VAQTA is a vaccine that helps prevent Hepatitis A. Hepatitis A is an infection of the liver.
  • It is a vaccine for people 12 months of age and older.

What do you need to know about VAQTA?

  • You cannot get Hepatitis A from VAQTA.
  • VAQTA will not prevent other types of Hepatitis, such as Hepatitis B.
  • VAQTA may not be effective in everyone who gets the shot.
  • VAQTA is not a treatment for those who already have Hepatitis A.

Who should not get VAQTA?

Do not get VAQTA if you or your child:

  • have had an allergic reaction to any ingredients of VAQTA, including neomycin. (See section titled “What is in VAQTA?” at the end of this leaflet.)
  • have had an allergic reaction to a previous dose of any Hepatitis A vaccine.

What should you tell the doctor or healthcare provider before getting VAQTA?

Tell your doctor or healthcare provider if you or your child:

  • are allergic to latex. The vial stopper contains dry natural latex rubber. Latex may cause severe allergic reactions in some people.
  • are pregnant or planning to get pregnant.
  • are breast-feeding.
  • have immune problems, like HIV or cancer.

If you have already gotten a Hepatitis A shot, talk to your doctor or healthcare provider to see if VAQTA is right for you.

The doctor will help decide if you or your child should get the shot.

What are the possible side effects of VAQTA?

The most common side effects seen with VAQTA are:

  • pain, soreness, redness, swelling, and warmth where you or your child got the shot
  • headache (adults 19 years and older)
  • fever (children 12 to 23 months)

If you or your child have any of the following problems, tell your doctor right away because these may be signs of an allergic reaction:

  • trouble breathing
  • wheezing
  • hives
  • rash

If you or your child has any side effects that worry you or seem to get worse, tell your doctor or healthcare provider right away.

There may be other side effects that are not listed. For more information, ask your doctor or healthcare provider.

You may report any side effects to your or your child’s doctor or directly to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or www.vaers.hhs.gov, or to Merck Sharp & Dohme LLC at 1-877-888-4231.

How is VAQTA given?

  • It is a shot given in the arm or thigh.
  • VAQTA is given in two doses on two different dates.

    • the 1st shot is given any time after 12 months of age.
    • the 2nd shot is given 6-18 months after the first shot.
  • If you miss the 2nd shot or if you get your 2nd shot too soon, talk to your doctor or healthcare provider. They will decide what to do.
  • How much VAQTA is given?

    • Children/Adolescents - 12 months through 18 years of age (0.5 mL dose)
    • Adults -19 years of age and older (1.0 mL dose)

What is in VAQTA?

Active ingredient: Hepatitis A virus, Inactivated.

Other ingredients: Aluminum hydroxyphosphate sulphate, sodium borate, sodium chloride, water.

This vaccine contains a trace amount of neomycin.

The vial stopper contains natural latex rubber.

VAQTA does not have any preservatives in it.

For more information, ask your doctor or healthcare provider. Keep this information in case you have questions later.

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: BLA 103606 · View the label on DailyMed

Revision date stated in the text: September 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Vaqta

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Inactivated Hepatitis A Virus Vaccine
Active ingredient Hepatitis A virus strain cr 326f antigen (formaldehyde inactivated)
Dosage form Injection, suspension
Route Intramuscular
Marketing status not in the current FDA NDC Directory
Company (applicant) Merck Sharp & Dohme LLC
FDA approval BLA 103606Biologics License Application (BLA)
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
25 IU/0.5 mL – 0.5 ml in 1 vial, single-dose / 10 in 1 carton NDC 0006-4831-01
25 IU/0.5 mL – 0.5 ml in 1 syringe / 10 in 1 carton NDC 0006-4095-01
50 IU/mL – 1 ml in 1 vial, single-dose / 10 in 1 carton NDC 0006-4841-01
50 IU/mL – 1 ml in 1 vial, single-dose / 1 in 1 carton NDC 0006-4841-01
50 IU/mL – 1 ml in 1 syringe / 10 in 1 carton NDC 0006-4096-01

Source: FDA drug labeling via NLM DailyMed, data as of November 17, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.